Announcement on Completion of Industrial and Commercial Registration of Changes in Controlling Shareholder's Equity Structure

Foci Pharmaceutical Co., Ltd.·June 12, 2026·1 page

✨ AI Summary

Lanzhou Foci Pharmaceutical Co., Ltd. announces the completion of industrial and commercial registration for changes in its controlling shareholder's equity structure. Gansu Pharmaceutical Investment Group Co., Ltd. has become the indirect controlling shareholder, holding 61.63% of the company's equity through Lanzhou Foci Pharmaceutical Industry Development Group Co., Ltd. This change does not alter the ultimate controlling party.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002644

Securities Abbreviation: Foci Pharmaceutical

Announcement Number: 2026-023

Lanzhou Foci Pharmaceutical Co., Ltd.

Announcement on Completion of Industrial and Commercial Registration of Changes in Controlling Shareholder's Equity Structure

The Company and all members of the Board of Directors guarantee the authenticity, accuracy, and completeness of the information disclosed in this announcement, and that there are no false records, misleading statements, or material omissions.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.